Take a deep dive into the scale and expanding value of the veterinary biologics sector as animal health takes center stage in global markets.

The Veterinary Biologics Market size is witnessing noteworthy expansion, driven by the increasing value placed on animal wellness in both livestock and companion‑animal segments. Recent data estimate the market at roughly USD 27.58 billion in 2024, with projections suggesting significant growth ahead. Market Research Future
This rise is anchored in growing pet ownership, enhanced livestock productivity demands, and the imperative of preventing zoonotic diseases, collectively elevating investment in biologics.
As technologies such as recombinant vaccines, gene therapies, and immunomodulators mature, the market size gains further impetus — companies are scaling manufacturing, expanding geographic reach, and embracing regulatory frameworks that favour advanced biologics.

FAQs
Q1: What factors are accelerating the market’s size growth?
A: Heightened awareness of animal health, increased companion‑animal spending, livestock disease prevention, and innovations in biologics.
Q2: How does the livestock segment influence market size?
A: Livestock is crucial: productivity demands and disease‑prevention needs in farm animals drive large scale biologics adoption.

Explore our latest reports